63results about How to "Reduce microbes" patented technology

A medical device for use in connection with a connector of an indwelling line for cleansing a surface of a septum of the connector is provided. The medical device includes a housing including a proximal portion defining a cavity containing a quantity of microbial reducing agent, a distal portion defining a cavity for selective coupling with the connector of the indwelling line, and a partition separating the proximal and distal cavities, wherein the proximal and distal cavities are in fluid communication with one another; and a deformable member overlying an end of the proximal portion for maintaining the microbial reducing agent within the proximal cavity thereof. The microbial reducing agent being dispensable into the distal cavity, at least when the medical device is connected to the connector of the indwelling line, to awash a surface of the connector of the indwelling line and reduce microbes present thereon.

A filter and filter material for providing or treating potable water is provided. The filter includes a housing having an inlet and an outlet, a filter material disposed within the housing, the filter material formed at least in part from a mixture of a plurality of mesoporous and microporous activated carbon particles. Preferably, at least some of the mesoporous activated carbon filter particles are coated with a cationic polymer, and even more preferably, at least some of the particles are coated with a cationic polymer and silver or a silver containing material. Kits comprising filters and information relating to the reduction, killing or removal of bacteria, viruses, microbials, and TTHM are also provided.

A device for reducing microorganisms comprising:an outer cylinder which liquid to be processed flows into;a mesh inner cylinder which is disposed inside the outer cylinder; andan ultrasonic oscillator which is disposed inside the mesh inner cylinder.

The present invention relates to a rotary device in which a drill for soil earthwork is rotatably mounted, wherein the drill comprises: a shaft part; a screw, formed along the outer circumferential surface of the shaft part, for earthwork and the transportation of soil generated by the earthwork; a rotary shaft, formed on the upper part of the shaft part; a connection socket, formed on the rotary shaft, for adjusting the length; and a fixed shaft part, formed on the lower part of the shaft part, for being inserted and rotated into the soil for earthwork. More specifically, the present invention relates to a portable power rotary device provided with a drill having earthwork and cut-off functions, wherein a pair of horizontal blades face each other on the connection part between the shaft part and the fixed shaft part; screws, formed in every other layer, are symmetrically and integrally connected to each other on the pair of horizontal blades, for transferring soil upwardly; cutting blades, which are symmetrical with each other, are inclined downwardly and integrally formed on the pair of horizontal blades; a plurality of vertical blades, formed to be spaced apart from each other at a predetermined distance, protrude vertically on the upper portion of the lower wing of the screw; and when performing earthwork, soil and tree roots are cut by the cutting blades, and soil lumps, transferred along the screw, are cut again by the vertical blades.

The presence of the ancient anti-inflammatory peptide α-melanocyte stimulating hormone (α-MSH [1-13], SYSMEHFRWGKPV) in barrier organs such as gut and skin suggests a role in the nonspecific (innate) host defense system. α-MSH and other amino acid sequences derived from α-MSH were determined to have antimicrobial influences, including against two major and representative cutaneous and mucosal pathogens: Staphylococcus aureus and Candida albicans. C-MSH peptides had antimicrobial effects against S. aureus and significantly reversed the enhancing effect of urokinase on S. aureus colony formation. α-MSH and other amino acid sequences reduced C. albicans viability and germination. α-MSH peptides also enhanced C. albicans killing by human neutrophils. The antimicrobial agent is selected from the group consisting of one or more peptides including the amino acid sequence KPV, one or more peptides including the amino acid sequence MEHFRWG, or a biologically functional equivalent of any of the foregoing. The most effective of the peptides were those bearing the C-terminal amino acid sequence of α-MSH, i.e., α-MSH (1-13), (6-13), and (11-13). The α-MSH “core” sequence (4-10), important for melanotropic effects, was also effective but significantly less potent. Antimicrobial influences of α-MSH peptides could be mediated by their well-known capacity to increase cellular cAMP; this messenger was significantly augmented in peptide-treated yeast. α-MSH has potent anti-inflammatory effects and is expected to be useful for treatment of inflammation in human and veterinary disorders. Reduced killing of pathogens is a detrimental consequence of therapy with corticosteroids and nonsteroidal anti-inflammatory drugs during infection. Therefore, anti-inflammatory agents based on α-MSH peptides that do not reduce microbial killing, but rather enhance it, would be very useful. The antimicrobial effects of these α-MSH peptides occurred over a broad range of concentrations including the physiological (picomolar) range.

An electrical liquid heating system and method of heating a liquid includes providing at least two spaced apart electrical conductors and applying an electrical energy source to the conductors. A liquid is directed into contact with the conductors thereby delivering electrical energy to the liquid. Electrical energy is delivered to the liquid at a power level that is sufficient to generate an electrical current to produce resistive heating of the liquid. The electrical energy may be delivered to the liquid at a power level that is sufficient to break at least some molecular bonds of molecules defining the liquid. A regulator may be provided for regulating delivery of electrical energy to the liquid.

A method for producing fermented edible plants alone or a mixture of edible plants and edible animals including the steps of: producing crushed edible plants or edible animal / plants; culturing a liquid mixture of grains, saccharides, filamentous fungi, and yeast for 24 to 36 hours to produce a mixed microbial broth; inoculating the edible plants or edible animal / plants with the mixed microbial broth, and firstly fermenting the edible plants or edible animal / plants for 3 to 8 days to produce first fermented edible plants or edible animal / plants; and inoculating the first fermented edible plants or edible animal / plants with bacteria, and secondly fermenting the first fermented edible plants or edible animal / plants for 6 to 12 days to produce second fermented edible plants or edible animal / plants. Further, adding the fermented edible plants or edible animal / plants produced by the above-described method into foods can provide storage stability, increase bioavailability, and improve flavor.

The present invention provides a photosensitizing composition for treatment of MRSA comprising a photosensitizer and chlorhexidine and a pharmaceutically acceptable carrier. The present invention also provides a method for reducing disease causing microbes comprising: applying the composition comprising a photosensitizer, chlorhexidine at a concentration of more than about 0.01% and less than about 2% v / v, and a pharmaceutically acceptable carrier to a treatment site; and applying light to the treatment site at a wavelength absorbed by the photosensitizer so as to reduce the microbes at the treatment site.

A method for insertion, maintenance, and removal of urethral catheters in mammals including humans includes steps for preventing or reducing the incidence of catheter associated urinary tract infections. In addition to sterile procedures currently practiced or as may be practiced in the future in connection with catheter use, the method includes the steps of applying an antiseptic, zwitterionic, and acidic skincare solution capable of preserving the stratum corneum to the perineum, meatus, and contiguous mucosa surrounding the insertion site before insertion, after insertion, periodically during the period of indwelling, in connection with any incidence of incontinence, and, optionally, before and after removal of the catheter. Application of the solution optionally is continued after catheter removal on a periodic basis until the threat of an infection associated with catheter use has passed, typically at least about five (5) to seven (7) days and up to thirty (30) days. The solution pH is desirably from about 4.4 to 5.5.